Wako Direct Bilirubin V, Models 996-23591, 412-22901, 992-23691, 998-23791
Enzymatic Method, Bilirubin. 510(k) K053132, from Wako Chemicals USA, Inc. (Richmond, VA). Product code JFM, class 2.
As of Nov 21, 2026, K053132 is an FDA 510(k) held by Wako Chemicals USA, Inc., substantially equivalent on Dec 30, 2005 after 52 days, with 2 recalls tied to it in FDA's recall database.
- Review time: 52 days
- Recalls: 2
- Cited as a predicate by: 2 devices
- Atellica® CH Diazo Direct Bilirubin (D_DBil)K223078 · Siemens Healthcare Diagnostics, Inc. · Jun 12, 2023
- Direct BilirubinK152343 · Randox Laboratories Limited · Feb 16, 2016
| Started | Recall | Status |
|---|---|---|
| Feb 13, 2020 | Z-1536-2020, Z-1538-2020Bilirubin assays may exhibit a positive bias with patients on eltrombopag therapy | Terminated |
- Document
- 510(k) summary (PDF) ↗
- Type
- Traditional
- Received
- Nov 8, 2005
- Review panel
- Clinical Chemistry
- Regulation
- 21 CFR 862.1110
One page per 510(k), De Novo and original PMA. Recalls are those FDA's recall database ties to this number; recalls of related devices that cite another number are not shown. Refreshed weekly. Predicates are read by Arca from the text of FDA's 510(k) summary PDFs, most of them scans: a device number counts when the summary names it as a predicate or as the device it is substantially equivalent to. About 97% of those read were right on a sample we checked by hand; summaries from before 2000 often name predicates without a number, so older devices show fewer. Pivotal studies are read by a model from FDA's De Novo decision summaries and PMA SSEDs; a count or result is shown only when its numbers appear in FDA's text. openFDA device 510(k), PMA and recall files